Inbrija vs. Apokyn

Are Inbrija and Apokyn the Same Thing?

Inbrija (levodopa inhalation powder) and Apokyn (apomorphine hydrochloride injection) are used to treat OFF episodes in patients with Parkinson's disease.

Inbrija and Apokyn belong to different drug classes. Inbrija is an aromatic amino acid and Apokyn is a dopamine agonist.

Side effects of Inbrija and Apokyn that are similar include nausea.

Side effects of Inbrija that are different from Apokyn include cough, upper respiratory tract infection, and discolored mucus.

Side effects of Apokyn that are different from Inbrija include injection site reactions (redness, swelling, pain, itching, bruising, or hardening of the skin), vomiting, headache, increased sweating, dizziness, drowsiness, yawning, runny nose, swelling in your hands or feet, pale skin, flushing (warmth, redness, or tingly feeling), sudden uncontrolled movements, and hallucinations (seeing and hearing things that are not real).

Both Inbrija and Apokyn may interact with metoclopramide.

Inbrija may also interact with monoamine oxidase inhibitors (MAOIs), dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone), isoniazid, and iron salts or multivitamins containing iron salts.

Apokyn may also interact with arsenic trioxide, bepridil, blood pressure medications, cisapride, chloroquine, halofantrine, metoclopramide, niacin, erectile dysfunction medications, narcotics, antibiotics, medicines to treat psychiatric disorders, and heart rhythm medicines.

Withdrawal symptoms may occur if you suddenly stop taking Inbrija or Apokyn.

What Are Possible Side Effects of Inbrija?

Common side effects of Inbrija include:

  • cough,
  • nausea,
  • upper respiratory tract infection, and
  • discolored mucus

What Are Possible Side Effects of Apokyn?

Common side effects of Apokyn include:

  • injection site reactions (redness, swelling, pain, itching, bruising, or hardening of the skin),
  • nausea,
  • vomiting,
  • headache,
  • increased sweating,
  • dizziness,
  • drowsiness,
  • yawning,
  • runny nose,
  • swelling in your hands or feet,
  • pale skin,
  • flushing (warmth, redness, or tingly feeling),
  • sudden uncontrolled movements, or
  • hallucinations (seeing and hearing things that are not real).

Tell your doctor if you have unlikely but serious side effects of Apokyn including:

  • uncontrolled movements,
  • mental/mood changes (e.g., depression, hallucinations, trouble sleeping),
  • muscle cramps or spasm,
  • swelling of the hands/legs/ankles/feet, or
  • unusual strong urges (such as increased gambling, increased sexual urges).

SLIDESHOW

Dementia, Alzheimer's Disease, and Aging Brains See Slideshow

What Is Inbrija?

Inbrija (levodopa inhalation powder) is an aromatic amino acid indicated for the intermittent treatment of OFF episodes in patients with Parkinson’s disease treated with carbidopa/levodopa.

What Is Apokyn?

Apokyn (apomorphine hydrochloride injection) is a dopamine agonist, which works by helping restore the balance of dopamine in the brain, used to treat "wearing-off" episodes (muscle stiffness, loss of muscle control) in people with advanced Parkinson's disease.

What Drugs Interact With Inbrija?

Inbrija may interact with monoamine oxidase inhibitors (MAOIs), dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone, metoclopramide), isoniazid, and iron salts or multivitamins containing iron salts. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Inbrija; it may harm a fetus. Inbrija passes into breast milk and may interfere with lactation. Consult your doctor before breastfeeding. Withdrawal symptoms may occur if you suddenly stop taking Inbrija.

What Drugs Interact With Apokyn?

Apokyn may interact with arsenic trioxide, bepridil, blood pressure medications, cisapride, chloroquine, halofantrine, metoclopramide, niacin, erectile dysfunction medications, narcotics, antibiotics, medicines to treat psychiatric disorders, or heart rhythm medicines. Tell your doctor all medications and supplements you use.

How Should Inbrija be Taken?

Apokyn is administered by subcutaneous (under the skin) injection. The dose is adjusted based on effectiveness and tolerance, starting at 0.2 mL (2 mg) and up to a maximum recommended dose of 0.6 mL (6 mg).

How Should Apokyn be Taken?

Apokyn must be taken exactly as directed. One tablet is taken every day, at the same time. Administration is continuous, with no interruption between pill packs.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Acorda Therapeutics. Inbrija Product Information.

www.inbrija.com/?

US WorldMeds, LLC. Apokyn Product Information.

https://www.apokyn.com/

Health Solutions From Our Sponsors